Gene expression in NKT cells: Defining a functionally distinct CD1d-restricted T cell subset

Current Opinion in Immunology

Volumn 13, Issue 5, 2001, Pages 555-561

  Wilson, S Brian ^a   Byrne, Michael C ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CYTOKINE; TRANSCRIPTION FACTOR;

ARTICLE; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; NATURAL KILLER CELL; NONHUMAN; REGULATORY MECHANISM; T LYMPHOCYTE; TYPES OF STUDY;

EID: 0035480031     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00258-2     Document Type: Review

References (50)

1. CD1 recognition by mouse NK1+ T-lymphocytes
2. - T-cells
3. Mouse CD1-specific NK1 T-cells: Development, specificity, and function
4. An interleukin 4 (IL-4)-independent pathway for CD4+ T-cell IL-4 production is revealed in IL-4 receptor-deficient mice
5. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T-cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
6. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
7. - T-cell defiency and IDDM in NOD/Lt mice
8. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls
9. + effector function against intracellular infection
10. Involvement of decidual Vα14 NKT-cells in abortion
11. CD1- reactive natural killer T-cells are required for development of systemic tolerance through an immune-privileged site
12. Requirement for Vα14 NKT-cells in IL-12-mediated rejection of tumors
13. CD1d on myeloid dendritic cells stimulates cytokine secretion and cytolytic activity of Vα24JαQ T-cells: A feedback mechanism for immune regulation
14. Highly conserved antigen-presenting function of CD1d molecules
15. Expression monitoring by hybridization to high-density oligonucleotide arrays
16. Exploring the new world of the genome with DNA microarrays
17. Cluster analysis and display of genome-wide expression patterns
18. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
19. Gene expression physiology and pathophysiology of the immune system
20. Molecular classification of cancer: Lass discovery and class prediction by gene expression monitoring
21. Activation changes the spectrum but not the diversity of genes expressed by T-cells
22. Gene regulation mediated by calcium signals in T-lymphocytes
23. Transcript imaging of the development of human T-helper cells using oligonucleotide arrays
24. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis
25. Extreme Th1 bias of invariant Vα24JαQ T-cells in type 1 diabetes
26. Induction of differentiation of pre-NKT-cells to mature Vα14 NKT-cells by granulocyte/macrophage colony-stimulating factor
27. Multiple differences in gene expression in regulatory Vα24JαQ T-cells from identical twins discordant for type I diabetes
28. Immunotherapy of NOD mice with bone marrow-derived dendritic cells
29. - α/β T-cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain
30. + thymocytes selected by MHC class I molecules
31. - T-cells in mice and humans
32. + T-cells by CD1-expressing cortical thymocytes
33. - cells
34. Natural T-cells in the human liver: Cytotoxic lymphocytes with dual T-cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T-cell receptor bearing cells
35. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T-cells
36. CD4+ and CD8+ T-cells acquire specific lymphokine secretion potentials during thymic maturation
37. Differential responses of invariant Vα24JαQ T-cells and MHC class II-restricted CD4+ T-cells to dexamethasone
38. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
39. NKT-cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
40. Potent expansion of human natural killer T-cells using a α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15
41. + T-cell-defective IL-4 production in the non-obese diabetic mouse
42. The natural killer (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT-cells
43. A distinct IL-18-induced pathway to fully activate NK T-lymphocytes independently from TCR engagement
44. + cells: New clues to their origin, specificity, and function
45. MIP-2 recruits NKT-cells to the spleen during tolerance induction
46. TRAIL expression by activated human CD4(+)Vα24 NKT-cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells
47. The Src family tyrosine kinase Fyn regulates natural killer T-cell development
48. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T-cells expressing invariant Vα 24 JαQ T-cell receptor α chains
49. The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues
50. + T-cells that promptly produce interleukin 4